Homa K. Ahmadzia, MD/MPH is a Maternal-Fetal Medicine specialist and Assistant Professor in the Department of Obstetrics and Gynecology. Dr Ahmadzia completed her undergraduate, medical school education, and Masters of Public Health at The George Washington University. She then completed her residency at Yale University where she was awarded the Outstanding Resident Teaching Award in both her second and third year of residency and also served as Administrative Chief resident. She completed her fellowship in Maternal-Fetal Medicine at Duke University.

Dr Ahmadzia has presented her research at numerous national and regional conferences including the American Institute of Ultrasound in Medicine, The Society for Maternal Fetal Medicine and The American Congress for Obstetricians and Gynecologists. She received the Charles B. Hammond Fund research award to fund her fellowship thesis project. She also attended the Excellence in Clinical Research course and NICHD Young Investigators Conference. During fellowship, she served on the Society of Maternal Fetal Medicine Global Health Committee. She has previously received the Clinical and Translational Science Institute KL2 Mentored Career Development Award through the GW-CNMC partnership with NIH and currently on a K23 Career Mentored Development Award from NHLBI. She has a specific clinic for Pregnancy and Hematology issues at GW. She also has other grant funded research from the FDA and Gates foundation as well as serves as the Medical Monitor for the Maternal-Fetal Medicine Unit Network.

Dr Ahmadzia’s clinical areas of interest include prenatal diagnosis, ultrasonography, management of high risk pregnancies, bleeding disorders and thrombophilias, preconception counseling and infectious diseases. She enjoys taking care of women during pregnancy and hopes to improve perinatal outcomes for women in the US and abroad through her clinical and research interests.

Dr. Homa K. Ahmadzia has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Coagulant Therapeutics, Haemosonics